Net Margin - Cutia Therapeutics (HKEX:2487) - Alpha Spread
C

Cutia Therapeutics
HKEX:2487

Watchlist Manager
Cutia Therapeutics
HKEX:2487
Watchlist
Price: 14.06 HKD -0.28% Market Closed
Market Cap: 4.3B HKD
Have any thoughts about
Cutia Therapeutics?
Write Note

Net Margin
Cutia Therapeutics

-263.7%
Current
-845%
Average
-7.7%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-263.7%
=
Net Income
-524.3m
/
Revenue
198.9m

Net Margin Across Competitors

Country CN
Market Cap 4.3B HKD
Net Margin
-264%
Country US
Market Cap 341.9B USD
Net Margin
10%
Country US
Market Cap 180.5B USD
Net Margin
10%
Country US
Market Cap 129B USD
Net Margin
32%
Country US
Market Cap 123.6B USD
Net Margin
-5%
Country US
Market Cap 104.5B USD
Net Margin
4%
Country US
Market Cap 94.1B EUR
Net Margin
-392%
Country AU
Market Cap 142.3B AUD
Net Margin
18%
Country US
Market Cap 39.3B EUR
Net Margin
-33%
Country US
Market Cap 38.5B USD
Net Margin
-557%
Country US
Market Cap 35.4B USD
Net Margin
-3%

Profitability Report

View the profitability report to see the full profitability analysis for Cutia Therapeutics.

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-263.7%
=
Net Income
-524.3m
/
Revenue
198.9m
What is the Net Margin of Cutia Therapeutics?

Based on Cutia Therapeutics's most recent financial statements, the company has Net Margin of -263.7%.